GlassScriptPhysician profile
Ethan Taub
NPI 1295002285
$1,482.18
in general payments reported to CMS, 2019-2025
10 companies · $791 in 2025
The $791 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83.74 · 2020: $123 · 2022: $23.66 · 2023: $200 · 2024: $261 · 2025: $791.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $677 · Food and Beverage: $575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $676.76 |
| Food and Beverage | $575.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $676.76 | 2025 | |
| Arteriocyte Medical Systems, INC. | $174.63 | 2023 | Magellan |
| Depuy Synthes Sales INC. | $123.00 | 2020 | |
| Davol INC. | $117.47 | 2024 | Phasix Mesh |
| Ethicon US, LLC | $113.81 | 2025 | Stratafix, Vistaseal, Ethicon |
| Kls-Martin L.P. | $88.93 | 2024 | |
| Acell, INC. | $83.74 | 2019 | |
| Kerecis Limited | $54.42 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Avita Medical Americas, LLC | $25.76 | 2023 | Recell |
| Organogenesis INC. | $23.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ethan Taub listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.